100
Participants
Start Date
March 5, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
March 30, 2029
Obinutuzumab
Participants will receive intravenous (IV) obinutuzumab 7 days prior to the first dose of glofitamab.
Glofitamab
Participants will receive IV glofitamab, both in combination with gemcitabine and oxaliplatin and as monotherapy, for up to 12 cycles (cycle length = 21 days).
Gemcitabine
Participants will receive IV gemcitabine in combination with glofitamab and oxaliplatin for up to 8 cycles (cycles length = 21 days).
Oxaliplatin
Participants will receive IV oxaliplatin in combination with glofitamab and gemcitabine for up to 8 cycles (cycle length = 21 days).
RECRUITING
Epworth Hospital, East Melbourne
RECRUITING
CAMPUS BENJAMIN FRANKLIN CharitéCentrum 14 Med.Klinik f.Hämatologie u.Onkologie, Berlin
RECRUITING
New York Oncology Hematology, P.C., Albany
RECRUITING
Hematology Oncology Associates of Central New York, East Syracuse
RECRUITING
Istituto Clinico Humanitas, Rozzano
RECRUITING
Irccs Istituto Europeo Di Oncologia (IEO), Milan
RECRUITING
Virginia Cancer Specialists, PC, Gainesville
RECRUITING
Virginia Oncology Associates - Virginia Beach, Virginia Beach
RECRUITING
A.O. Spedali Civili Di Brescia-P.O. Spedali Civili, Brescia
RECRUITING
North Florida/ South Georgia VA Medical Center, Gainesville
RECRUITING
Orlando Health Cancer Institute, Orlando
RECRUITING
Mount Sinai Comprehensive Cancer Center, Miami
RECRUITING
CHU de Bordeaux, Pessac
RECRUITING
Chu de Montpellier-St Eloi, Montpellier
RECRUITING
CHU DE RENNES - CHU Pontchaillou, Rennes
RECRUITING
Chu De Tours, Tours
RECRUITING
Tennessee Oncology, Nashville
RECRUITING
Tennessee Oncology, Chattanooga
RECRUITING
CHU de Grenoble, La Tronche
RECRUITING
Otto von Guericke Uni Magdeburg Uniklinik, Magdeburg
RECRUITING
University of Kentucky - Markey Cancer Center, Lexington
RECRUITING
"IRCCS Istituto Romagnolo per lo studio dei tumori Dino Amadori", Meldola
RECRUITING
Universitätsklinikum Köln, Cologne
RECRUITING
Cancer Care Specialists of Central Illinois, Swansea
RECRUITING
Nebraska Cancer Specialists, Omaha
RECRUITING
Mary Bird Perkins Cancer Ctr, Baton Rouge
RECRUITING
Texas Oncology- Northeast Texas, Tyler
RECRUITING
Baylor Scott & White Health, Temple
RECRUITING
Texas Oncology - Gulf Coast, The Woodlands
RECRUITING
Rocky Mountain Cancer Centers, LLP, Aurora
RECRUITING
Istituto Nazionale Tumori Irccs Fondazione g. Pascale, Napoli
RECRUITING
St Luke?s Cancer Institute, Boise
RECRUITING
Valkyrie Clinical Trials, Los Angeles
RECRUITING
Los Angeles Cancer Network, Glendale
RECRUITING
Providence Medical Foundation, Fullerton
RECRUITING
Zuckerberg San Francisco General Hospital, San Francisco
RECRUITING
Providence Portland Medical Center, Portland
RECRUITING
Providence St. Vincent Medical Center, Portland
RECRUITING
Oncology Associates of Oregon, P.C, Eugene
RECRUITING
Northwest Medical Specialties, Tacoma
RECRUITING
Alaska Oncology & Hematology, LLC, Anchorage
RECRUITING
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance
RECRUITING
Boston Medical Center, Boston
RECRUITING
Arthur J.E. Child Comprehensive Cancer Center, Calgary
RECRUITING
CancerCare Manitoba (CCMB), Winnipeg
RECRUITING
Seoul National University Bundang Hospital, Seongnam-si
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
Hoffmann-La Roche
INDUSTRY